Try our mobile app

Published: 2020-10-27 16:10:54 ET
<<<  go to VECO company page
EX-99.1 2 veco-20201027xex99d1.htm EX-99.1

EXHIBIT 99.1

A picture containing drawing

Description generated with very high confidence

VEECO REPORTS THIRD QUARTER 2020 FINANCIAL RESULTS

Third Quarter 2020 Highlights:

Revenues of $112.1 million, compared with $109.0 million in the same period last year
GAAP net income of $0.6 million, or $0.01 per diluted share, compared with a loss of $11.8 million, or $0.25 loss per diluted share in the same period last year
Non-GAAP net income of $11.0 million, or $0.22 per diluted share, compared with $2.6 million, or $0.05 per diluted share in the same period last year

Plainview, N.Y., Oct 27, 2020 -- Veeco Instruments Inc. (Nasdaq: VECO) today announced financial results for its third quarter ended September 30, 2020. Results are reported in accordance with U.S. generally accepted accounting principles (“GAAP”) and are also reported adjusting for certain items (“Non-GAAP”). A reconciliation between GAAP and Non-GAAP operating results is provided at the end of this press release.  

U.S. Dollars in millions, except per share data

GAAP Results

 

Q3 '20

Q3 '19

Revenue

$

112.1

$

109.0

Net income (loss)

$

0.6

$

(11.8)

Diluted earnings (loss) per share

$

0.01

$

(0.25)

Non-GAAP Results

 

Q3 '20

Q3 '19

Net income (loss)

$

11.0

$

2.6

Operating income (loss)

$

14.1

$

4.0

Diluted earnings (loss) per share

$

0.22

$

0.05

“I am proud of the Veeco team for achieving another quarter of solid performance. While maintaining all health and safety measures, we continue to operate at normal capacity,” commented William J. Miller, Ph.D., Chief Executive Officer.

“We are pleased with our advancing profitability in the quarter which was driven by our ion beam technologies sold into the Data Storage market. Our non-GAAP operating income improved significantly year-on-year, demonstrating the early effectiveness of our transformation. Given our visibility, we expect continued strength in our overall business and feel confident about our future performance,” continued Dr. Miller. “We began to deliver evaluation systems in support of our longer term growth strategy in the semiconductor and compound semiconductor markets and we expect these initiatives to contribute to our growth in 2022 and beyond.”

1


Guidance and Outlook

The following guidance is provided for Veeco’s fourth quarter 2020:

Revenue is expected in the range of $120 million to $135 million
GAAP earnings per share are expected in the range of $0.02 to $0.17
Non-GAAP earnings per share are expected in the range of $0.22 to $0.37

Please refer to the tables at the end of this press release for further details.

Conference Call Information

A conference call reviewing these results has been scheduled for today, October 27, 2020 starting at 5:00pm ET. To join the call, dial 1-800-437-2398 (toll free) or 1-929-477-0577 and use passcode 9869378. Participants may also access a live webcast of the call by visiting the investor relations section of Veeco's website at ir.veeco.com. A replay of the webcast will be made available on the Veeco website that evening. We will post an accompanying slide presentation to our website prior to the beginning of the call.

About Veeco

Veeco (NASDAQ: VECO) is an innovative manufacturer of semiconductor process equipment. Our proven ion beam, laser annealing, lithography, MOCVD, and single wafer etch & clean technologies play an integral role in the fabrication and packaging of advanced semiconductor devices. With equipment designed to optimize performance, yield and cost of ownership, Veeco holds leading technology positions in the markets we serve. To learn more about Veeco’s systems and service offerings, visit www.veeco.com.

Forward-looking Statements

This press release contains “forward-looking statements”, within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, as amended, that are based on management’s expectations, estimates, projections and assumptions. Words such as “expects,” “anticipates,” “plans,” “believes,” “scheduled,” “estimates” and variations of these words and similar expressions are intended to identify forward-looking statements. Forward-looking statements include, but are not limited to, those regarding anticipated growth and trends in our businesses and markets, industry outlooks and demand drivers, our investment and growth strategies, our development of new products and technologies, our business outlook for current and future periods, the impact of the COVID-19 pandemic and the affects thereof on our operations and financial results; and other statements that are not historical facts. These statements and their underlying assumptions are subject to risks and uncertainties and are not guarantees of future performance. Factors that could cause actual results to differ materially from those expressed or implied by such statements include, without limitation: the level of demand for our products; global economic and industry conditions; the effects of regional or global health epidemics, including the effects of the COVID-19 pandemic on the Company’s operations and on those of our customers and suppliers; global trade issues, including the ongoing trade disputes between the U.S. and China, and changes in trade and export license policies; our dependency on third-party outsourcing partners; the timing of customer orders; our ability to develop, deliver and support new products and technologies; our ability to expand our current markets, increase market share and develop new markets; the concentrated nature of our customer base; our ability to obtain and protect intellectual property rights in key technologies; our ability to achieve the objectives of operational and strategic initiatives and attract, motivate and retain key employees; the variability of results among products and segments, and our ability to accurately forecast future results, market conditions, and customer requirements; the impact of our indebtedness, including our convertible senior notes and our capped call transactions; and other risks and uncertainties described in our SEC filings on Forms 10-K, 10-Q and 8-K. All forward-looking statements speak only to management’s expectations, estimates, projections and assumptions as of the date of this press release or, in the case of any document referenced herein or incorporated by reference, the date of that document. The Company does not undertake any obligation to update or publicly revise any forward-looking statements to reflect events, circumstances or changes in expectations after the date of this press release.

-financial tables attached-

Veeco Contacts:

Investors:Anthony Bencivenga (516) 252-1438abencivenga@veeco.com

Media:Kevin Long (516) 714-3978klong@veeco.com

2


Veeco Instruments Inc. and Subsidiaries
Condensed Consolidated Statements of Operations

(in thousands, except per share amounts)
(unaudited)

Three months ended September 30,

Nine months ended September 30,

 

    

2020

    

2019

    

2020

    

2019

 

Net sales

 

$

112,078

 

$

108,954

 

$

315,216

 

$

306,147

Cost of sales

 

62,936

 

66,731

 

177,761

 

192,924

Gross profit

 

49,142

 

42,223

 

137,455

 

113,223

Operating expenses, net:

Research and development

 

19,129

 

22,639

 

57,577

 

68,901

Selling, general, and administrative

 

19,415

 

20,962

 

55,541

 

60,620

Amortization of intangible assets

 

3,831

 

4,312

 

11,502

 

12,773

Restructuring

 

 

1,828

 

1,097

 

3,874

Asset impairment

 

 

 

281

 

Other operating expense (income), net

 

(218)

 

(153)

 

(502)

 

(232)

Total operating expenses, net

 

42,157

 

49,588

 

125,496

 

145,936

Operating income (loss)

 

6,985

 

(7,365)

 

11,959

 

(32,713)

Interest expense, net

 

(6,194)

 

(4,330)

 

(16,673)

 

(12,742)

Loss on extinguishment of debt

(3,046)

Income (loss) before income taxes

 

791

 

(11,695)

 

(7,760)

 

(45,455)

Income tax expense (benefit)

 

211

 

72

 

530

 

407

Net income (loss)

 

$

580

 

$

(11,767)

 

$

(8,290)

 

$

(45,862)

Income (loss) per common share:

Basic

 

$

0.01

 

$

(0.25)

 

$

(0.17)

 

$

(0.97)

Diluted

 

$

0.01

 

$

(0.25)

 

$

(0.17)

 

$

(0.97)

Weighted average number of shares:

Basic

 

48,341

 

47,489

 

48,327

 

47,361

Diluted

 

49,174

 

47,489

 

48,327

 

47,361

3


Veeco Instruments Inc. and Subsidiaries
Condensed Consolidated Balance Sheets

(in thousands)

September 30,

December 31,

    

2020

    

2019

(unaudited)

Assets

Current assets:

Cash and cash equivalents

$

147,588

$

129,294

Restricted cash

 

664

 

657

Short-term investments

 

161,585

 

115,252

Accounts receivable, net

 

80,212

 

45,666

Contract assets

 

21,342

 

25,351

Inventories

 

143,469

 

133,067

Deferred cost of sales

 

1,677

 

445

Prepaid expenses and other current assets

 

15,948

 

14,966

Assets held for sale

11,180

Total current assets

 

572,485

 

475,878

Property, plant and equipment, net

 

65,811

 

75,711

Operating lease right-of-use assets

10,522

 

14,453

Intangible assets, net

 

50,016

 

61,518

Goodwill

 

181,943

 

181,943

Deferred income taxes

 

1,555

 

1,549

Other assets

 

7,293

 

7,036

Total assets

$

889,625

$

818,088

Liabilities and stockholders’ equity

Current liabilities:

Accounts payable

$

33,837

$

21,281

Accrued expenses and other current liabilities

 

40,667

 

41,243

Customer deposits and deferred revenue

 

71,539

 

54,870

Income taxes payable

 

891

 

830

Total current liabilities

 

146,934

 

118,224

Deferred income taxes

 

5,984

 

5,648

Long-term debt

 

320,818

 

300,068

Operating lease long-term liabilities

6,793

 

10,300

Other liabilities

 

11,003

 

9,336

Total liabilities

 

491,532

 

443,576

Total stockholders’ equity

 

398,093

 

374,512

Total liabilities and stockholders’ equity

$

889,625

$

818,088

4


Veeco Instruments Inc. and Subsidiaries
Reconciliation of GAAP to Non-GAAP Financial Data

(in thousands, except per share amounts)
(unaudited)

Non-GAAP Adjustments

 

Share-Based

 

Three months ended September 30, 2020

    

GAAP

    

Compensation

    

Amortization

    

Other

    

Non-GAAP

 

Net sales

$

112,078

$

112,078

 

Gross profit

 

49,142

 

389

 

288

 

49,819

Gross margin

 

43.8

%

 

44.5

%

Operating expenses

 

42,157

 

(2,553)

(3,831)

(28)

35,745

Operating income (loss)

 

6,985

 

2,942

3,831

 

316

^

14,074

Net income (loss)

 

580

 

2,942

 

3,831

 

3,654

^

11,007

Income (loss) per common share:

Basic

$

0.01

$

0.23

Diluted

 

0.01

 

0.22

Weighted average number of shares:

Basic

 

48,341

 

48,341

Diluted

 

49,174

 

49,174


^

- See table below for additional details.

Veeco Instruments Inc. and Subsidiaries

Other Non-GAAP Adjustments

(in thousands)
(unaudited)

Three months ended September 30, 2020

    

Release of inventory fair value step-up associated with the Ultratech purchase accounting

 

273

Depreciation of PP&E fair value step-up associated with the Ultratech purchase accounting

 

43

Subtotal

316

Non-cash interest expense

 

3,504

Non-GAAP tax adjustment *

 

(166)

Total Other

 

3,654


*

- The ‘with or without’ method is utilized to determine the income tax effect of all Non-GAAP adjustments.

These tables include financial measures adjusted for the impact of certain items; these financial measures are therefore not calculated in accordance with U.S. generally accepted accounting principles (“GAAP”). These Non-GAAP financial measures exclude items such as: share-based compensation expense; charges relating to restructuring initiatives; non-cash asset impairments; certain other non-operating gains and losses; and acquisition-related items such as transaction costs, non-cash amortization of acquired intangible assets, and certain integration costs.

These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended to facilitate meaningful comparisons to historical operating results, competitors’ operating results, and estimates made by securities analysts. Management is evaluated on key performance metrics including Non-GAAP Operating income (loss), which is used to determine management incentive compensation as well as to forecast future periods. These Non-GAAP financial measures may be useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, similar Non-GAAP financial measures have historically been reported to investors; the inclusion of comparable numbers provides consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial measures used in this news release to their most directly comparable GAAP financial measures.

5


Veeco Instruments Inc. and Subsidiaries

Reconciliation of GAAP to Non-GAAP Financial Data

(in thousands, except per share amounts)
(unaudited)

Non-GAAP Adjustments

 

Share-based

Three months ended September 30, 2019

    

GAAP

    

Compensation

    

Amortization

    

Other

    

Non-GAAP

Net sales

$

108,954

$

108,954

Gross profit

 

42,223

 

383

 

1,316

 

43,922

Gross margin

 

38.8

%  

40.3

%

Operating expenses

 

49,588

 

(3,400)

(4,312)

(1,920)

39,956

Operating income (loss)

 

(7,365)

 

3,783

4,312

 

3,236

^

3,966

Net income (loss)

 

(11,767)

 

3,783

 

4,312

 

6,302

^

2,630

Income (loss) per common share:

Basic

$

(0.25)

$

0.06

Diluted

 

(0.25)

0.05

Weighted average number of shares:

Basic

 

47,489

47,495

Diluted

 

47,489

47,898


^

- See table below for additional details.

Veeco Instruments Inc. and Subsidiaries

Other Non-GAAP Adjustments

(in thousands)
(unaudited)

Three months ended September 30, 2019

Restructuring

    

1,828

Release of inventory fair value step-up associated with the Ultratech purchase accounting

 

1,270

Depreciation of PP&E fair value step-up associated with the Ultratech purchase accounting

 

138

Subtotal

3,236

Non-cash interest expense

 

3,199

Non-GAAP tax adjustment *

 

(133)

Total Other

 

6,302


*

- The ‘with or without’ method is utilized to determine the income tax effect of all Non-GAAP adjustments.

These tables include financial measures adjusted for the impact of certain items; these financial measures are therefore not calculated in accordance with U.S. generally accepted accounting principles (“GAAP”). These Non-GAAP financial measures exclude items such as: share-based compensation expense; charges relating to restructuring initiatives; non-cash asset impairments; certain other non-operating gains and losses; and acquisition-related items such as transaction costs, non-cash amortization of acquired intangible assets, and certain integration costs.

These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended to facilitate meaningful comparisons to historical operating results, competitors’ operating results, and estimates made by securities analysts. Management is evaluated on key performance metrics including Non-GAAP Operating income (loss), which is used to determine management incentive compensation as well as to forecast future periods. These Non-GAAP financial measures may be useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, similar Non-GAAP financial measures have historically been reported to investors; the inclusion of comparable numbers provides consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial measures used in this news release to their most directly comparable GAAP financial measures.

6


Veeco Instruments Inc. and Subsidiaries

Reconciliation of GAAP Net Income (loss) to Non-GAAP Operating Income (loss)

(in thousands)
(unaudited)

    

Three months ended

    

Three months ended

September 30, 2020

September 30, 2019

GAAP Net income (loss)

$

580

$

(11,767)

Share-based compensation

 

2,942

 

3,783

Amortization

 

3,831

 

4,312

Restructuring

 

 

1,828

Release of inventory fair value step-up associated with the Ultratech purchase accounting

 

273

 

1,270

Depreciation of PP&E fair value step-up associated with the Ultratech purchase accounting

 

43

 

138

Interest (income) expense, net

 

6,194

 

4,330

Income tax expense (benefit)

 

211

 

72

Non-GAAP Operating income (loss)

$

14,074

$

3,966

This table includes financial measures adjusted for the impact of certain items; these financial measures are therefore not calculated in accordance with U.S. generally accepted accounting principles (“GAAP”). These Non-GAAP financial measures exclude items such as: share-based compensation expense; charges relating to restructuring initiatives; non-cash asset impairments; certain other non-operating gains and losses; and acquisition-related items such as transaction costs, non-cash amortization of acquired intangible assets, and certain integration costs.

These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended to facilitate meaningful comparisons to historical operating results, competitors’ operating results, and estimates made by securities analysts. Management is evaluated on key performance metrics including Non-GAAP Operating income (loss), which is used to determine management incentive compensation as well as to forecast future periods. These Non-GAAP financial measures may be useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, similar Non-GAAP financial measures have historically been reported to investors; the inclusion of comparable numbers provides consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial measures used in this news release to their most directly comparable GAAP financial measures.

7


Veeco Instruments Inc. and Subsidiaries

Reconciliation of GAAP to Non-GAAP Financial Data

(in millions, except per share amounts)

(unaudited)

Non-GAAP Adjustments

 

Guidance for the three months ending

Share-based

 

December 31, 2020

GAAP

Compensation

Amortization

   Other    

Non-GAAP

 

Net sales

    

$

120

    

-

    

$

135

    

    

    

    

$

120

    

-

    

$

135

Gross profit

 

50

 

-

 

60

 

 

 

 

50

 

-

 

60

Gross margin

 

42%

-

 

44%

 

 

 

42%

-

 

44%

Operating expenses

43

 

-

 

45

(3)

(4)

36

 

-

 

38

Operating income (loss)

7

-

15

3

4

14

-

22

Net income (loss)

$

1

 

-

$

9

 

3

 

4

3

$

11

 

-

$

19

Income (loss) per diluted common share

$

0.02

 

-

$

0.17

 

  

 

  

 

  

$

0.22

 

-

$

0.37

Weighted average number of shares

 

50

 

50

 

 

 

 

50

 

50

Veeco Instruments Inc. and Subsidiaries

Reconciliation of GAAP Net Income (loss) to Non-GAAP Operating Income (Loss)

(in millions)
(unaudited)

Guidance for the three months ending December 31, 2020

    

    

    

GAAP Net income (loss)

$

1

 

-

$

9

Share-based compensation

 

3

 

-

 

3

Amortization

 

4

 

-

 

4

Interest expense, net

 

6

 

-

 

6

Non-GAAP Operating income (loss)

$

14

 

-

$

22

Note: Amounts may not calculate precisely due to rounding.

These tables include financial measures adjusted for the impact of certain items; these financial measures are therefore not calculated in accordance with U.S. generally accepted accounting principles (“GAAP”). These Non-GAAP financial measures exclude items such as: share-based compensation expense; charges relating to restructuring initiatives; non-cash asset impairments; certain other non-operating gains and losses; and acquisition-related items such as transaction costs, non-cash amortization of acquired intangible assets, and certain integration costs.

These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended to facilitate meaningful comparisons to historical operating results, competitors’ operating results, and estimates made by securities analysts. Management is evaluated on key performance metrics including Non-GAAP Operating income (loss), which is used to determine management incentive compensation as well as to forecast future periods. These Non-GAAP financial measures may be useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, similar Non-GAAP financial measures have historically been reported to investors; the inclusion of comparable numbers provides consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial measures used in this news release to their most directly comparable GAAP financial measures.

8